 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| China's Advanced Therapies Hospital for Cancer |
Case Study 9:
Liver Cancer
Name: Mr. Jian from Gaoxiong City, Taiwan
Age: 54
Diagnosis upon Admission: Liver cancer
Medical History:
2006 October B ultrasound and CT discovered a lesion with
diameter size of 1.2cm.
2006 December had a needle biopsy of the liver tumour, liver
cancer according to pathological diagnosis.
Was treated with Chinese patent medicine at the local hospital
for 3 months.
2007 February CT reexamination: tumour size about 3.2cm.
Condition upon admission:
Heart, lungs and stomach normal. Liver-spleen subcostal no
metastasis.
Lab results:
Glu: 8.41mmol/l, ALT: 82u/l, AST:54.5 u/l, ALP: 118.5u/l,
HbsAg: +ve, HbeAb: +ve, HbcAb: +ve.
No other remarkable results.
Treatment:
2007 April 4 Under CT guidance and local anaesthesia, thirty
I¹²⁵ particles were implanted together with injection of 5-FU,
DDP, Lipiodol ultra-fluid, absorbable gelatin sponge. After the
operation administered anti-inflammation, haemostatic and
support therapies. One course of biotherapy.
Condition after treatment:
Living well.
Liver Cancer
Name: Mr. Jian from Gaoxiong City, Taiwan
Age: 54
Diagnosis upon Admission: Liver cancer
Medical History:
2006 October B ultrasound and CT discovered a lesion with
diameter size of 1.2cm.
2006 December had a needle biopsy of the liver tumour, liver
cancer according to pathological diagnosis.
Was treated with Chinese patent medicine at the local hospital
for 3 months.
2007 February CT reexamination: tumour size about 3.2cm.
Condition upon admission:
Heart, lungs and stomach normal. Liver-spleen subcostal no
metastasis.
Lab results:
Glu: 8.41mmol/l, ALT: 82u/l, AST:54.5 u/l, ALP: 118.5u/l,
HbsAg: +ve, HbeAb: +ve, HbcAb: +ve.
No other remarkable results.
Treatment:
2007 April 4 Under CT guidance and local anaesthesia, thirty
I¹²⁵ particles were implanted together with injection of 5-FU,
DDP, Lipiodol ultra-fluid, absorbable gelatin sponge. After the
operation administered anti-inflammation, haemostatic and
support therapies. One course of biotherapy.
Condition after treatment:
Living well.
| Copyright © 2008 Capetown All rights reserved. |